Recursion Pharmaceuticals (RXRX) PT Lowered to $11 at Needham
Tweet Send to a Friend
(Updated - September 4, 2024 7:12 AM EDT)
Needham analyst Gil Blum lowered the price target on Recursion Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Gil Blum lowered the price target on Recursion Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
